| UHC Medicaid Medical & Drug | Long-Acting Injectable Antiretroviral Agents for HIV – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Luxturna® (Voretigene Neparvovec-Rzyl) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Medical Therapies for Enzyme Deficiencies – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Neurophysiologic Testing and Monitoring – Community Plan Medical Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Niktimvo™ (Axatilimab-Csfr) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Nplate® (Romiplostim) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Ophthalmologic Complement Inhibitors – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Ophthalmologic Vascular Endothelial Growth Factor (VEGF) Inhibitors – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Parsabiv® (Etelcalcetide) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |